Business Description
Naturhouse Health SA
ISIN : ES0105043006
Total Employee Number:
166Compare
Compare
Traded in other countries / regions
NTH.Spain2NH.Germany0R9G.UK IPO Date
2015-04-28Description
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.95 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 0.16 | |||||
Interest Coverage | 150.49 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 9.43 | |||||
Beneish M-Score | -3.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.1 | |||||
3-Year EBITDA Growth Rate | -1.4 | |||||
3-Year EPS without NRI Growth Rate | 1.6 | |||||
3-Year FCF Growth Rate | 24.1 | |||||
3-Year Book Growth Rate | -13.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -3.96 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -1.08 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.65 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 1.22 | |||||
Days Inventory | 85.86 | |||||
Days Sales Outstanding | 15.6 | |||||
Days Payable | 103.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 1.79 | |||||
Shareholder Yield % | 13.9 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.95 | |||||
Operating Margin % | 27.8 | |||||
Net Margin % | 21.19 | |||||
EBITDA Margin % | 31.32 | |||||
FCF Margin % | 24.51 | |||||
OCF Margin % | 25.5 | |||||
ROE % | 40.23 | |||||
ROA % | 25.29 | |||||
ROIC % | 61.83 | |||||
3-Year ROIIC % | -4.9 | |||||
ROC (Joel Greenblatt) % | 435.34 | |||||
ROCE % | 47.29 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.24 | |||||
Forward PE Ratio | 10.05 | |||||
PE Ratio without NRI | 15.42 | |||||
Shiller PE Ratio | 9.81 | |||||
Price-to-Owner-Earnings | 14.31 | |||||
PS Ratio | 3.26 | |||||
PB Ratio | 8.75 | |||||
Price-to-Tangible-Book | 8.87 | |||||
Price-to-Free-Cash-Flow | 13.28 | |||||
Price-to-Operating-Cash-Flow | 12.76 | |||||
EV-to-EBIT | 10.26 | |||||
EV-to-EBITDA | 9.48 | |||||
EV-to-Revenue | 2.98 | |||||
EV-to-FCF | 12.27 | |||||
Price-to-GF-Value | 1.6 | |||||
Price-to-Projected-FCF | 1.05 | |||||
Price-to-Median-PS-Value | 1.64 | |||||
Price-to-Graham-Number | 2.47 | |||||
| Price-to-Net-Current-Asset-Value | 37.69 | |||||
Earnings Yield (Greenblatt) % | 9.74 | |||||
FCF Yield % | 7.61 | |||||
Forward Rate of Return (Yacktman) % | 4.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Naturhouse Health SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 47.629 | ||
| EPS (TTM) (€) | 0.17 | ||
| Beta | 0.1464 | ||
| 3-Year Sharpe Ratio | -57.26 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 10.34 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 1.5075 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 1.5075 - 1.5075 | ||
| Shares Outstanding (Mil) | 59.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Naturhouse Health SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Naturhouse Health SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.050000 Cash Dividend | 2026-07-23 | In 20 days | ||
| EUR 0.050000 Cash Dividend | 2026-04-16 | 1.51 (+0.00%) | ||
| EUR 0.100000 Cash Dividend | 2026-01-30 | 1.51 (+0.00%) | ||
| EUR 0.100000 Cash Dividend | 2025-10-22 | 1.51 (+0.00%) | ||
| EUR 0.100000 Cash Dividend | 2025-07-03 | 1.51 (+0.00%) | ||
| EUR 0.100000 Cash Dividend | 2025-04-03 | 1.51 (+0.00%) | ||
| EUR 0.100000 Cash Dividend | 2024-08-29 | 1.51 (+0.00%) |
Show
Entries
Naturhouse Health SA Frequently Asked Questions
What is Naturhouse Health SA(CHIX:NTHe)'s stock price today?
The current price of CHIX:NTHe is €1.51. The 52 week high of CHIX:NTHe is €1.51 and 52 week low is €1.51.
When is next earnings date of Naturhouse Health SA(CHIX:NTHe)?
The next earnings date of Naturhouse Health SA(CHIX:NTHe) is .
Does Naturhouse Health SA(CHIX:NTHe) pay dividends? If so, how much?
Naturhouse Health SA(CHIX:NTHe) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Naturhouse Health SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers